This study investigates the effectiveness of an investigational medication in preventing the worsening of kidney and heart disease in patients with Type 2 diabetes. Type 2 diabetes is a condition where the body does not use insulin properly, leading to high blood sugar levels. This can cause damage to various organs, including the kidneys and heart.
Participants will be randomly assigned to different study arms. Some will receive the investigational medication, while others may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
- Who can participate: Adults aged 18 and older with Type 2 diabetes and kidney disease may be eligible to participate.
- Study details: Participants will receive either the investigational medication or a placebo.
